IFNA16 Antikörper (AA 101-189) (Cy3)
Kurzübersicht für IFNA16 Antikörper (AA 101-189) (Cy3) (ABIN717224)
Target
Alle IFNA16 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 101-189
-
Spezifität
- Possible cross-reactivity with Human IFNA4, IFNA7, IFNA10, IFNA14, IFNA17 because of sequence similarity
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human IFNA16
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- IFNA16 (Interferon, alpha 16 (IFNA16))
-
Andere Bezeichnung
- IFNA16
-
Hintergrund
-
Synonyms: Interferon alpha-16, IFN-alpha-16, Interferon alpha-WA, IFN-alpha-N-protein, Interferon alpha-WA, IFN-alphaO, IFN16_HUMAN, IFNA16.
Background: IFNA16 is produced by macrophages and has antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase.
-
Gen-ID
- 3449
-
UniProt
- P05015
-
Pathways
- JAK-STAT Signalweg, Hepatitis C
Target
-